Search results
Found 31107 matches for
NEOPANC-01 is a window of opportunity study looking to assess gene expression in patients with resectable pancreatic cancer. It aims to evaluate the utility of whole transcriptome RNA sequencing as a potential biomarker for future window-of-opportunity trials that will assess existing and/or new treatments for pancreatic cancer. An understanding of the variability in the transcriptomic signature between biopsies will also inform power calculations for future studies. Lastly, the data generated will be available for use as historical controls for future studies. 2 sets of biopsy samples will be taken throughout the trial. Firstly during an endoscopic ultrasound procedure and then again, up to 6 weeks later, during the patients surgery to remove the cancer. Once all patients have been recruited, the mRNA from the samples will be sequenced and analysed. Further samples will also be taken at the same time points for storage into a biobank and for use in future research. This is a single site study opening at the Churchill Hospital looking to recruit 10 patients over 18 months.
OCTRU Training Bite: GEN-072 Requests for Unplanned Deletions/Changes *Online*
Thursday, 11 September 2025, 10am to 11am
OCTRU Training Bite: GEN-072 Requests for Unplanned Deletions *online*
Wednesday, 20 August 2025, 11am to 11.45am
OCTRU Training Bite: GEN-072 Requests for Unplanned Deletions *online*
Tuesday, 12 August 2025, 2pm to 2.45pm
OCTRU Training Bite: GEN-072 Requests for Unplanned Deletions *online*
Monday, 04 August 2025, 10am to 10.45am
OCTRU Extended Training Bite: Introduction to the Trial Master File (TMF) *online*
Tuesday, 12 August 2025, 10am to 12pm
Trials Expertise Session: Effective planning and management of trial sample collections
Wednesday, 05 November 2025, 11.30am to 12.30pm
Trials Expertise Session: The role of a Trial Manager in a Trial Management Group (TMG) *online*
Thursday, 12 June 2025, 10am to 11am
Trials Expertise Session: Communication skills in Clinical Trials for Trial Managers *online*
Wednesday, 26 March 2025, 10am to 11am
Trials Expertise Session: Site Feasibility Questionnaires (SFQ) & Site selection *Hybrid*
Wednesday, 15 October 2025, 1.30pm to 2.30pm